MetaVia Inc. — Director's Dealing 2016

Aug 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2016-08-10

Reporting Person: Oniciu Carmen Daniela (Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-10	Common Stock	C	2237	—	Acquired	152156	Direct
2016-08-10	Common Stock	J	245	$6.7059	Acquired	152401	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-10	Series A Convertible Preferred Stock	$	C	2237	Disposed		Common Stock (2237)	Direct

Footnotes

F1: The Series A Convertible Preferred Stock converted into shares of common stock, par value $0.001 per share (the "Common Stock"), of Gemphire Therapeutics Inc. (the "Company") on a one-for-one basis immediately prior to the closing of the Company's initial public offering and had no expiration date.

F2: Represents shares of Common Stock issued for payment of accrued dividends on the Series A Convertible Preferred Stock.